Brief: NextCell Pharma Gets Order Of About SEK 350,000
04/04/2019 10:28
April 4 (Reuters) - NextCell Pharma AB NXTCL.TE :
* GETS ORDER WITH VALUE ABOUT SEK 350,000
* CLIENT IS A FOREIGN BIOTECH COMPANY
Source text for Eikon: ID:nWkr1Q587G
Further company coverage: NXTCL.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln